Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Statistics in Medicine|September 1, 1991
Stochastic methods for short term projections of symptomatic HIV diseaseC J Mode, D Fife, S M TroyEuropean Journal of Clinical Pharmacology|August 22, 2000
Psychomotor effects of zaleplon and thioridazine coadministrationJ Hetta, J E Broman, M Darwish, et al.Journal of Clinical Pharmacology|May 29, 1998
The influence of cimetidine on the disposition kinetics of the antidepressant venlafaxineS M Troy, R Rudolph, M Mayersohn, et al.Journal of Clinical Pharmacology|April 1, 1995
The pharmacokinetics of venlafaxine when given in a twice-daily regimenS M Troy, V D Parker, R J Fruncillo, et al.Biopharmaceutics & Drug Disposition|April 22, 1999
Zaleplon pharmacokinetics and absolute bioavailabilityA S Rosen, P Fournié, M Darwish, et al.Clinical Pharmacology and Therapeutics|March 1, 1992
The effect of renal disease on tolrestat pharmacokineticsS M Troy, D R Hicks, M Kraml, et al.Clinical Pharmacology and Therapeutics|September 1, 1988
Effect of chronic renal failure on oxaprozin multiple-dose pharmacokineticsP R Audet, J A Knowles, S M Troy, et al.Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanolS M Troy, M B Turner, M Unruh, et al.Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxineS M Troy, V P Parker, D R Hicks, et al.Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithiumS M Troy, V D Parker, D R Hicks, et al.Pageof 2